| Curtis James Boyd Iii, DO | |
|
625 United Dr Ste 360, Conway, AR 72032 | |
| (501) 358-6941 | |
| (501) 358-6951 |
| Full Name | Curtis James Boyd Iii |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 8 Years |
| Location | 625 United Dr Ste 360, Conway, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346501020 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northwest Arkansas Ob/gyn Assoc.,plc | 2668478926 | 6 |
| Western Missouri Medical Center | 2062493653 | 6 |
News Archive
According to a survey, colorectal cancer patients rate their quality of life after treatment as good, particularly if they have to cope with small physical restrictions only.
After visiting Ghana on a recent tour to examine poverty reduction strategies and progress on the Millennium Development Goals (MDGs), Jeffrey Sachs, director of the Earth Institute at Columbia University and "one of the world's most prominent development economists, says Ghana is proving to be one of the strongest performers on the [MDGs] in Africa and unlike some of its African counterparts is likely to fulfill them by the 2015 deadline," the Christian Science Monitor reports.
Lentigen Corporation, a biotechnology company specializing in the development and manufacture of lentiviral gene delivery technologies, announced today that it has received a National Institutes of Health (NIH) small business innovation research (SBIR) grant for a program on "A Novel Method of Generating Hepatitis C Virus-Like Particles using Lentivirus". In this program, Lentigen will collaborate with Epixis SA (Paris, France).
Cancer cells, like bacteria, can develop resistance to drug therapy. In fact, research suggests strongly that multidrug-resistant cancer cells that remain alive after chemotherapy are responsible for the reappearance of tumors and the poor prognosis for patients whose cancer recurs.
› Verified 6 days ago
| Entity Name | Cooper Clinic Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154341931 PECOS PAC ID: 1153219621 Enrollment ID: O20040607000412 |
News Archive
According to a survey, colorectal cancer patients rate their quality of life after treatment as good, particularly if they have to cope with small physical restrictions only.
After visiting Ghana on a recent tour to examine poverty reduction strategies and progress on the Millennium Development Goals (MDGs), Jeffrey Sachs, director of the Earth Institute at Columbia University and "one of the world's most prominent development economists, says Ghana is proving to be one of the strongest performers on the [MDGs] in Africa and unlike some of its African counterparts is likely to fulfill them by the 2015 deadline," the Christian Science Monitor reports.
Lentigen Corporation, a biotechnology company specializing in the development and manufacture of lentiviral gene delivery technologies, announced today that it has received a National Institutes of Health (NIH) small business innovation research (SBIR) grant for a program on "A Novel Method of Generating Hepatitis C Virus-Like Particles using Lentivirus". In this program, Lentigen will collaborate with Epixis SA (Paris, France).
Cancer cells, like bacteria, can develop resistance to drug therapy. In fact, research suggests strongly that multidrug-resistant cancer cells that remain alive after chemotherapy are responsible for the reappearance of tumors and the poor prognosis for patients whose cancer recurs.
› Verified 6 days ago
| Entity Name | Northwest Arkansas Ob/gyn Assoc.,plc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053344234 PECOS PAC ID: 2668478926 Enrollment ID: O20061024000589 |
News Archive
According to a survey, colorectal cancer patients rate their quality of life after treatment as good, particularly if they have to cope with small physical restrictions only.
After visiting Ghana on a recent tour to examine poverty reduction strategies and progress on the Millennium Development Goals (MDGs), Jeffrey Sachs, director of the Earth Institute at Columbia University and "one of the world's most prominent development economists, says Ghana is proving to be one of the strongest performers on the [MDGs] in Africa and unlike some of its African counterparts is likely to fulfill them by the 2015 deadline," the Christian Science Monitor reports.
Lentigen Corporation, a biotechnology company specializing in the development and manufacture of lentiviral gene delivery technologies, announced today that it has received a National Institutes of Health (NIH) small business innovation research (SBIR) grant for a program on "A Novel Method of Generating Hepatitis C Virus-Like Particles using Lentivirus". In this program, Lentigen will collaborate with Epixis SA (Paris, France).
Cancer cells, like bacteria, can develop resistance to drug therapy. In fact, research suggests strongly that multidrug-resistant cancer cells that remain alive after chemotherapy are responsible for the reappearance of tumors and the poor prognosis for patients whose cancer recurs.
› Verified 6 days ago
| Entity Name | Obhg Arkansas Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962862920 PECOS PAC ID: 4880984558 Enrollment ID: O20160608001838 |
News Archive
According to a survey, colorectal cancer patients rate their quality of life after treatment as good, particularly if they have to cope with small physical restrictions only.
After visiting Ghana on a recent tour to examine poverty reduction strategies and progress on the Millennium Development Goals (MDGs), Jeffrey Sachs, director of the Earth Institute at Columbia University and "one of the world's most prominent development economists, says Ghana is proving to be one of the strongest performers on the [MDGs] in Africa and unlike some of its African counterparts is likely to fulfill them by the 2015 deadline," the Christian Science Monitor reports.
Lentigen Corporation, a biotechnology company specializing in the development and manufacture of lentiviral gene delivery technologies, announced today that it has received a National Institutes of Health (NIH) small business innovation research (SBIR) grant for a program on "A Novel Method of Generating Hepatitis C Virus-Like Particles using Lentivirus". In this program, Lentigen will collaborate with Epixis SA (Paris, France).
Cancer cells, like bacteria, can develop resistance to drug therapy. In fact, research suggests strongly that multidrug-resistant cancer cells that remain alive after chemotherapy are responsible for the reappearance of tumors and the poor prognosis for patients whose cancer recurs.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Curtis James Boyd Iii, DO 625 United Dr Ste 360, Conway, AR 72032-7831 Ph: (501) 358-6941 | Curtis James Boyd Iii, DO 625 United Dr Ste 360, Conway, AR 72032 Ph: (501) 358-6941 |
News Archive
According to a survey, colorectal cancer patients rate their quality of life after treatment as good, particularly if they have to cope with small physical restrictions only.
After visiting Ghana on a recent tour to examine poverty reduction strategies and progress on the Millennium Development Goals (MDGs), Jeffrey Sachs, director of the Earth Institute at Columbia University and "one of the world's most prominent development economists, says Ghana is proving to be one of the strongest performers on the [MDGs] in Africa and unlike some of its African counterparts is likely to fulfill them by the 2015 deadline," the Christian Science Monitor reports.
Lentigen Corporation, a biotechnology company specializing in the development and manufacture of lentiviral gene delivery technologies, announced today that it has received a National Institutes of Health (NIH) small business innovation research (SBIR) grant for a program on "A Novel Method of Generating Hepatitis C Virus-Like Particles using Lentivirus". In this program, Lentigen will collaborate with Epixis SA (Paris, France).
Cancer cells, like bacteria, can develop resistance to drug therapy. In fact, research suggests strongly that multidrug-resistant cancer cells that remain alive after chemotherapy are responsible for the reappearance of tumors and the poor prognosis for patients whose cancer recurs.
› Verified 6 days ago
Keitha Dewitt Holland, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2180 Ada Avenue, Suite 300, Conway, AR 72034 Phone: 501-327-6547 Fax: 501-327-3478 | |
Paul Lewis Mcchristian, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2519 College Ave, Conway, AR 72034 Phone: 501-327-6547 Fax: 501-327-9715 | |
Dr. Brandie Mcnabb Martin, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2519 College Ave, Conway, AR 72034 Phone: 501-450-3920 Fax: 501-450-7718 | |
Dr. Debra C Lawrence, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2519 College Ave, Conway, AR 72034 Phone: 501-450-3920 Fax: 501-450-7718 | |
Audrey Tobey, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 625 United Dr Ste 420, Conway, AR 72032 Phone: 501-358-6941 | |
Phillip Thomas Gullic, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2180 Ada Avenue, Suite 300, Conway, AR 72034 Phone: 501-327-6547 Fax: 501-327-9715 | |
Andrew Axley Cole, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2180 Ada Avenue, Suite 300, Conway, AR 72034 Phone: 501-327-6547 Fax: 501-327-9715 |